Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.70
-0.04-2.30%
At close: -
$1.71
0.010.59%
After Hours: Mar 28, 6:06 PM EDT
Comments
Loading...
OPKO Health Analyst Ratings and Price Targets | NASDAQ:OPK | Benzinga
OPKO Health Inc has a consensus price target of $2.81 based on the ratings of 4 analysts. The high is $3 issued by HC Wainwright & Co. on March 19, 2025. The low is $2.25 issued by Barrington Research on March 12, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Barrington Research on March 19, 2025, March 12, 2025, and March 12, 2025, respectively. With an average price target of $2.75 between HC Wainwright & Co., HC Wainwright & Co., and Barrington Research, there's an implied 60.82% upside for OPKO Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Barrington Research
Piper Sandler
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for OPKO Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/19/2025 | Buy Now | 75.44% | HC Wainwright & Co. | Yi Chen60% | $3 → $3 | Reiterates | Buy → Buy | Get Alert |
| 03/12/2025 | Buy Now | 75.44% | HC Wainwright & Co. | Yi Chen60% | $3 → $3 | Reiterates | Buy → Buy | Get Alert |
| 03/12/2025 | Buy Now | 31.58% | Barrington Research | Michael Petusky52% | $2.25 → $2.25 | Maintains | Outperform | Get Alert |
| 03/03/2025 | Buy Now | 75.44% | HC Wainwright & Co. | Yi Chen60% | $3 → $3 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2025 | Buy Now | 31.58% | Barrington Research | Michael Petusky52% | $2.25 → $2.25 | Maintains | Outperform | Get Alert |
| 01/08/2025 | Buy Now | 75.44% | HC Wainwright & Co. | Yi Chen60% | $3 → $3 | Maintains | Buy | Get Alert |
| 11/08/2024 | Buy Now | 31.58% | Barrington Research | Michael Petusky52% | $2.25 → $2.25 | Maintains | Outperform | Get Alert |
| 09/26/2024 | Buy Now | 75.44% | HC Wainwright & Co. | Yi Chen60% | $3 → $3 | Reiterates | Buy → Buy | Get Alert |
| 09/20/2024 | Buy Now | 31.58% | Barrington Research | Michael Petusky52% | $2.25 → $2.25 | Maintains | Outperform | Get Alert |
| 09/17/2024 | Buy Now | 75.44% | Piper Sandler | Edward Tenthoff51% | $3 → $3 | Reiterates | Overweight → Overweight | Get Alert |
| 09/17/2024 | Buy Now | 75.44% | HC Wainwright & Co. | Yi Chen60% | $3 → $3 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2024 | Buy Now | 31.58% | Barrington Research | Michael Petusky52% | $1.5 → $2.25 | Maintains | Outperform | Get Alert |
| 07/18/2024 | Buy Now | 75.44% | Piper Sandler | Edward Tenthoff51% | $5 → $3 | Maintains | Overweight | Get Alert |
| 05/08/2024 | Buy Now | 75.44% | HC Wainwright & Co. | Yi Chen60% | $3 → $3 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2024 | Buy Now | 75.44% | HC Wainwright & Co. | — | → $3 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2024 | Buy Now | -12.28% | Barrington Research | Michael Petusky52% | $1.5 → $1.5 | Maintains | Outperform | Get Alert |
| 04/01/2024 | Buy Now | 192.4% | Piper Sandler | Edward Tenthoff51% | → $5 | Reiterates | Overweight → Overweight | Get Alert |
| 02/28/2024 | Buy Now | 75.44% | HC Wainwright & Co. | Yi Chen60% | $3 → $3 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2024 | Buy Now | -12.28% | Barrington Research | Michael Petusky52% | $2 → $1.5 | Maintains | Outperform | Get Alert |
| 08/07/2023 | Buy Now | 75.44% | HC Wainwright & Co. | Yi Chen60% | → $3 | Reiterates | Buy → Buy | Get Alert |
| 06/29/2023 | Buy Now | 16.96% | Barrington Research | Michael Petusky52% | → $2 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/05/2023 | Buy Now | 75.44% | HC Wainwright & Co. | Yi Chen60% | → $3 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | Buy Now | 75.44% | HC Wainwright & Co. | Yi Chen60% | → $3 | Reiterates | → Buy | Get Alert |
| 02/24/2023 | Buy Now | 75.44% | HC Wainwright & Co. | Yi Chen60% | → $3 | Reiterates | → Buy | Get Alert |
| 12/15/2022 | Buy Now | 75.44% | HC Wainwright & Co. | Yi Chen60% | → $3 | Initiates | → Buy | Get Alert |
| 08/05/2022 | Buy Now | 133.92% | Piper Sandler | Edward Tenthoff51% | $5 → $4 | Maintains | Overweight | Get Alert |
| 05/10/2022 | Buy Now | 192.4% | Piper Sandler | Edward Tenthoff51% | $6 → $5 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for OPKO Health (OPK) stock?
The latest price target for OPKO Health (NASDAQ:OPK) was reported by HC Wainwright & Co. on March 19, 2025. The analyst firm set a price target for $3.00 expecting OPK to rise to within 12 months (a possible 75.44% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for OPKO Health (OPK)?
The latest analyst rating for OPKO Health (NASDAQ:OPK) was provided by HC Wainwright & Co., and OPKO Health reiterated their buy rating.
When was the last upgrade for OPKO Health (OPK)?
The last upgrade for OPKO Health Inc happened on June 29, 2023 when Barrington Research raised their price target to $2. Barrington Research previously had a market perform for OPKO Health Inc.
When was the last downgrade for OPKO Health (OPK)?
There is no last downgrade for OPKO Health.
When is the next analyst rating going to be posted or updated for OPKO Health (OPK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OPKO Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OPKO Health was filed on March 19, 2025 so you should expect the next rating to be made available sometime around March 19, 2026.
Is the Analyst Rating OPKO Health (OPK) correct?
While ratings are subjective and will change, the latest OPKO Health (OPK) rating was a reiterated with a price target of $3.00 to $3.00. The current price OPKO Health (OPK) is trading at is $1.71, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.